Consuming caffeine with recreational psychostimulant drugs like MDMA (ecstasy) can cause severe acute adverse reactions and long-term harm. Caffeine increases toxicity by disrupting body temperature regulation, causing heart damage, and lowering the seizure threshold. In rats, co-administering caffeine with MDMA dramatically raises core body temperature, heart rate, and death rates, and worsens long-term damage to serotonin neurons. The interaction involves MDMA boosting dopamine release while caffeine blocks adenosine receptors and inhibits PDE. Similar mechanisms apply to interactions with cocaine, d-amphetamine, and ephedrine. Understanding these mechanisms helps guide interventions for managing severe reactions and drug-related toxicity from combined caffeine and psychostimulant use.
Caffeine worsens the rise in body temperature caused by MDMA ('Ecstasy') in rats. The interaction depends on the combined release of the neurotransmitters serotonin and catecholamines (like dopamine). Blocking dopamine D1, serotonin 5-HT2, or alpha-1 adrenergic receptors prevented both MDMA-induced hyperthermia and its exacerbation by caffeine. Caffeine's effect was mimicked by combining a PDE-4 inhibitor with an adenosine A2A receptor antagonist, but not with an A1 receptor antagonist. The findings suggest that caffeine exacerbates MDMA hyperthermia through a mechanism involving both adenosine A2A receptor antagonism and phosphodiesterase inhibition.